Among the symptoms of COVID-19 fever, general malaise, pain and aches, myalgia, fatigue, and headache can affect the quality of life of patients, even after the end of the acute phase of the infection and can be long lasting. The current treatment of these symptoms, also because COVID-19 patients have been asked not to use non-steroidal anti-inflammatory drugs (NSAIDs), in particular ibuprofen are often unsatisfactory. Among the above mentioned symptoms malaise and fatigue seem the most difficult to treat. In this case report we describe the use of kratom (Mitragyna speciosa) by a patient with confirmed COVID-19 infection. What we observed was a fast and sustained relieve of the above mentioned symptoms.

Can kratom (Mitragyna speciosa) alleviate COVID-19 pain? A case study / Metastasio, A.; Prevete, E.; Singh, D.; Grundmann, O.; Prozialeck, W. C.; Veltri, C.; Bersani, G.; Corazza, O.. - In: FRONTIERS IN PSYCHIATRY. - ISSN 1664-0640. - 11:(2020), pp. 1-6. [10.3389/fpsyt.2020.594816]

Can kratom (Mitragyna speciosa) alleviate COVID-19 pain? A case study

E. Prevete
Secondo
Membro del Collaboration Group
;
G. Bersani
Penultimo
Conceptualization
;
O. Corazza
Ultimo
Conceptualization
2020

Abstract

Among the symptoms of COVID-19 fever, general malaise, pain and aches, myalgia, fatigue, and headache can affect the quality of life of patients, even after the end of the acute phase of the infection and can be long lasting. The current treatment of these symptoms, also because COVID-19 patients have been asked not to use non-steroidal anti-inflammatory drugs (NSAIDs), in particular ibuprofen are often unsatisfactory. Among the above mentioned symptoms malaise and fatigue seem the most difficult to treat. In this case report we describe the use of kratom (Mitragyna speciosa) by a patient with confirmed COVID-19 infection. What we observed was a fast and sustained relieve of the above mentioned symptoms.
2020
COVID-19; kratom; long covid; new psychoactive substances; new treatments; opioid; stimulants.
01 Pubblicazione su rivista::01i Case report
Can kratom (Mitragyna speciosa) alleviate COVID-19 pain? A case study / Metastasio, A.; Prevete, E.; Singh, D.; Grundmann, O.; Prozialeck, W. C.; Veltri, C.; Bersani, G.; Corazza, O.. - In: FRONTIERS IN PSYCHIATRY. - ISSN 1664-0640. - 11:(2020), pp. 1-6. [10.3389/fpsyt.2020.594816]
File allegati a questo prodotto
File Dimensione Formato  
Metastasio_Can-kratom_2020.pdf

accesso aperto

Note: https://www.frontiersin.org/articles/10.3389/fpsyt.2020.594816/full
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 199.79 kB
Formato Adobe PDF
199.79 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1474279
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
social impact